In addition, mice treated with rIL-22 had decreased levels of inflammatory cytokines, namely Lcn-2 (Figure 1E), one of the most sensitive markers of inflammation in IBD patients (25), as well as TNF-α and IL-6 (Figures 1F, G). This evidence concerns the gene TNF and inflammatory bowel disease.